Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.
Bullous pemphigoid has high morbidity and mortality, especially in people with comorbidities common to older adults, yet no Food and Drug Administration–approved therapies for BP exist.
1. Skin-related quality of life is associated with the type of autoimmune bullous disease and flare state. 2. Skin-related quality of life can inform changes in disease state and severity of flares. Evidence Rating Level: 2 (Good) Study Rundown: Autoimmune bullous disease (AIBD) is an overarching term for multiple chronic relapsing-remitting diseases of cutaneous blisters